Berberine also increases production of GLP-1 from intestinal L-cells
Until recently we didn't have a way to treat leptin resistance even though most Doctors recognised that it was involved in many cases of obesity
Waist circumference, systolic blood pressure (BP), triglycerides, and non-high-density lipoprotein cholesterol (non-HDL-C) improved significantly, indicating broad cardiometabolic improvements
paracasei [75] and Bacopa monnieri [145] reversed the ES-induced increase of apoptotic markers BAX [45, 81, 117], caspase 3 [75, 81, 117, 145], pro-caspase 3 [45] and pro-caspase 9 [45] and decrease in anti-apoptotic marker Bcl-2 [81, 117]
Beginning in July 2026, CMS will launch a temporary Medicare GLP-1 Bridge program offering eligible Part D beneficiaries access to certain GLP-1 weight loss medications for obesity at an estimated $50 monthly copay
To schedule a private consultation, please call our office at (305) 763-8832 or fill out this contact form to get started
